Kemler D, Dahley O, Roßwag S, Litfin M & Kassel O (2016) The LIM domain protein nTRIP6 acts as a co-repressor for the transcription factor MEF2C in myoblasts. Sci Rep 6: 27746.
Chakraborty A, Diefenbacher ME, Mylona A, Kassel O & Behrens A (2015) The E3 ubiquitin ligase Trim7 mediates c-Jun/AP-1 activation by Ras signalling. Nat Commun 6: 6782
Diefenbacher ME, Reich D, Dahley O, Kemler D, Litfin M, Herrlich P & Kassel O (2014) The LIM Domain Protein nTRIP6 Recruits the Mediator Complex to AP-1-Regulated Promoters. PLoS ONE 9: e97549
Baumann P, Thiele W, Cremers N, Muppala S, Krachulec J, Diefenbacher M, Kassel O, Mudduluru G, Allgayer H, Frame M & Sleeman JP (2012) CD24 interacts with and promotes the activity of c-src within lipid rafts in breast cancer cells, thereby increasing integrin-dependent adhesion. Cell Mol Life Sci 69: 435–448
Röder IV, Strack S, Reischl M, Dahley O, Khan MM, Kassel O, Zaccolo M & Rudolf R (2012) Participation of Myosin va and pka type I in the regeneration of neuromuscular junctions. PLoS ONE 7: e40860
M. Diefenbacher, M. Litfin, P. Herrlich, O. Kassel. 2010. The nuclear isoform of the LIM domain protein Trip6 integrates activating and repressing signals at the promoter-bound glucocorticoid receptor. Mol Cell Endocrinol 320(1-2):58-66
M. Diefenbacher, S. Sekula, C. Heibock, J.V. Maier, M. Litfin, H. van Dam, M. Castellazzi, P. Herrlich, O. Kassel. 2008. Restriction to Fos family members of Trip6-dependent coactivation and GR-dependent trans-repression of activator protein-1. Mol Endocrinol 22:1767-1780
O. Kassel, P. Herrlich. 2007. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol Cell Endocrinol 275:13-29.
O. Kassel, S. Schneider, C. Heilbock, M. Litfin, M. Göttlicher, and P. Herrlich. 2004. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-κB-regulated promoters. Genes Dev 18: 2518-2528.
C.A. Da Silva, C. Heilbock, O. Kassel, and N. Frossard. 2003. Transcription of stem cell factor (SCF) is potentiated by glucocorticoids and interleukin-1beta through concerted regulation of a GRE-like and an NF- kappaB response element. Faseb J 17: 2334-6.
C.A. Da Silva, O. Kassel, E. Mathieu, G. Massard, B. Gasser, and N. Frossard. 2002. Inhibition by glucocorticoids of the interleukin-1beta-enhanced expression of the mast cell growth factor SCF. Br J Pharmacol 135: 1634-40.
O. Kassel, and A.C. Cato. 2002. Mast cells as targets for glucocorticoids in the treatment of allergic disorders. Ernst Schering Res Found Workshop: 153-76.
C. Olgart Hoglund, F. de Blay, J.P. Oster, C. Duvernelle, O. Kassel, G. Pauli, and N. Frossard. 2002. Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J 20: 1110-6.
O. Kassel, A. Sancono, J. Kratzschmar, B. Kreft, M. Stassen, and A.C. Cato. 2001. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. Embo J 20: 7108-16.
O. Kassel, C. da Silva, and N. Frossard. 2001. The stem cell factor, its properties and potential role in the airways. Pulm Pharmacol Ther 14: 277-88.
O. Kassel, F. de Blay, C. Duvernelle, C. Olgart, D. Israel-Biet, P. Krieger, L. Moreau, C. Muller, G. Pauli, and N. Frossard. 2001. Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin Exp Allergy 31: 1432-40.
D. Scherrer, F. Schmidlin, E.B. Haddad, O. Kassel, Y. Landry, and J.P. Gies. 1999. Glucocorticoids increase bradykinin B2 receptor gene transcription in cultured guinea-pig tracheal smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol 359: 153-9.
O. Kassel, F. Schmidlin, C. Duvernelle, B. Gasser, G. Massard, and N. Frossard. 1999. Human bronchial smooth muscle cells in culture produce stem cell factor. Eur Respir J 13: 951-4.
F. de Blay, P. Krieger, F. Spirlet, L. Moreau, C. Duvernelle, O. Kassel, M.C. Kopferschmitt, B. Gasser, C. Demangeat, G. Pauli, and N. Frossard. 1999. Repeated inhalation of low doses of cat allergen that do not induce clinical symptoms increases bronchial hyperresponsiveness and eosinophil cationic protein levels. Int Arch Allergy Immunol 120: 158-65.
O. Kassel, F. Schmidlin, C. Duvernelle, F. de Blay, and N. Frossard. 1998. Up- and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor stem cell factor by human lung fibroblasts in culture. Mol Pharmacol 54: 1073-9.
O. Kassel, W. Stevens, and N. Frossard. 1996. [New hypotheses in asthma: the mastocytes]. Rev Pneumol Clin 52: 59-63.
O. Kassel, Y. Amrani, Y. Landry, and C. Bronner. 1995. Mast cell activation involves plasma membrane potential- and thapsigargin-sensitive intracellular calcium pools. Fundam Clin Pharmacol 9: 531-9.
Y. Okayama, C. Petit-Frere, O. Kassel, A. Semper, D. Quint, M.J. Tunon-de-Lara, P. Bradding, S.T. Holgate, and M.K. Church. 1995. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol 155: 1796-808.
Y. Okayama, T.C. Hunt, O. Kassel, L.K. Ashman, and M.K. Church. 1994. Assessment of the anti-c-kit monoclonal antibody YB5.B8 in affinity magnetic enrichment of human lung mast cells. J Immunol Methods 169: 153-61.
Y. Amrani, A. Da Silva, O. Kassel, and C. Bronner. 1994. Biphasic increase in cytosolic free calcium induced by bradykinin and histamine in cultured tracheal smooth muscle cells: is the sustained phase artifactual? Naunyn Schmiedebergs Arch Pharmacol 350: 662-9.
F. De Blay, O. Kassel, M. Chapman, M. Ott, A. Verot, and G. Pauli. 1992. [Demonstration of major cockroach allergens in house dust by the ELISA test]. Presse Med 21: 1685.
Updated: June 24, 2016